Breast Cancer Now’s chief executive, Claire Rowney, said:
“We know breast screening is a key tool for detecting breast cancer early, when survival rates are almost 100%, so it’s hugely encouraging to see the government’s announcement of support for research into technology that could improve breast cancer detection.
“However, while new innovations and technologies have the potential to improve breast screening, there are fundamental issues in the breast screening programme right now that must be addressed in order for them to be rolled out successfully. This includes ensuring that the programme is supported by a sufficient screening workforce, with the right training, as well as up to date IT and data systems.
“And, of course, any changes to the breast screening programme must be supported by robust evidence that demonstrates any new innovation or tool, is safe and effective for women in the UK. We look forward to seeing the outcome of this trial.”
ENDS